CTNI-09. TRIDENT PHASE 3 TRIAL (EF-32): FIRST-LINE TUMOR TREATING FIELDS (TTFields; 200 KHZ) CONCOMITANT WITH CHEMO-RADIATION, FOLLOWED BY MAINTENANCE TTFIELDS/TEMOZOLOMIDE IN NEWLY-DIAGNOSED GLIOBLASTOMA

Authors: Wenyin Shi, Lawrence Kleinberg, Suriya Jeyapalan, Samuel Goldlust, Seema Nagpal, Stephanie Combs, David Roberge, Ryo Nishikawa, David Reardon, Rachel Grossman, Martin Glas

Published: 2021-11-18

DOI: 10.1093/neuonc/noab196.234

Source: Full article

CTNI-09. TRIDENT PHASE 3 TRIAL (EF-32): FIRST-LINE TUMOR TREATING FIELDS (TTFields; 200 KHZ) CONCOMITANT WITH CHEMO-RADIATION, FOLLOWED BY MAINTENANCE TTFIELDS/TEMOZOLOMIDE IN NEWLY-DIAGNOSED GLIOBLASTOMA

Abstract